GlaxoSmithKline India reports higher second-quarter profit on specialty medicine growth

Core Insights - GlaxoSmithKline Pharmaceuticals in India reported a slight increase in second-quarter profit, driven by consistent demand for its specialty medicine portfolio [1] Company Summary - The company's second-quarter profit showed a positive trend, indicating resilience in its financial performance [1] - The growth in profit is attributed to the steady demand for specialty medicines, highlighting the strength of this segment within the company's overall portfolio [1] Industry Summary - The pharmaceutical industry in India continues to experience stable demand for specialty medicines, which may suggest a favorable market environment for companies operating in this sector [1]